Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>News>This Article

ARI Launches New Assay Prep System for Drug Discovery

Published: Tuesday, November 06, 2012
Last Updated: Tuesday, November 06, 2012
Bookmark and Share
Non-contact dispenser sets a new benchmark for flexible, low-volume assay assembly.

Art Robbins Instruments (ARI) has announced the launch of their Cobra 148 non-contact dispensers. These affordably-priced liquid handling systems were designed for use in a wide range of drug discovery applications and enable low-volume, non-contact reagent dispensing for assay assembly and plate preparation.

Rapid, reliable assembly of assay reagents is critical for biochemical and cell-based assay development, especially when low-volume assays are required.

The Cobra 148 systems finally provide assay developers with the freedom and flexibility to design assays using precious or costly reagents and cells without constraint, dispensing them at low volumes in a microplate format.

Scientists have complete control over the volume dispensed, and can set individual well dispense volumes to as low as 300 nanoliters, enabling complex concentration gradients and even sparse-matrix assay development strategies.

Researchers in drug discovery and other areas that require a large number of data points per assay are now also able to dispense a broad range of volumes of up to four reagents into 96-, 384- and 1536-well microplates.

With an option for on-the-fly dispensing, 300 nanoliters can be dispensed into an entire 384 well microplate in 14 seconds. Twenty-five microliters require only 39 seconds.

Aspiration and dispensing from microplates is a standard feature in the 1 and 4 channel models, virtually eliminating dead volumes and preserving precious reagents.

A dedicated 8-channel bulk dispensing system is available for very high throughput applications.

“Assembling microplate-based assays is a fundamental part of drug discovery and life science research, the instrumentation has to be fast, robust and fit seamlessly into user’s workflows” commented Art Robbins, founder of ARI.

Robbins continued, “We’ve applied our years of experience in developing non-contact dispensers for protein crystallography applications to the Cobra 148 systems so that researchers can take advantage of the same speed and reliability for their assay development and screening applications.”

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,100+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
Targeting Cannabinoid CB2 Receptors in the CNS
With endogenous cannabinoids considered as a potential target to combat CNS diseases, this article examines the role of CB2R could play in fighting some disorders.
Bacterial Genes Boost Current in Human Cells
Borrowing and tweaking bacterial genes to enhance electrical activity might treat heart, nervous system injury.
Less Frequent Cervical Cancer Screening
HPV-vaccinated women may only need one screening every 5 to 10 years with screening starting later in life.
Cocoa Compound Linked to Some Cardiovascular Biomarker Improvements
The study highlights the urgent need for large, long-term RCTs that improve understanding of how the short-term benefits of cocoa flavanol intake on cardiometabolic biomarkers may be translated into clinical outcomes.
Untangling a Cause of Memory Loss in Neurodegenerative Diseases
The mouse study identifies a possible therapeutic target for a family of disorders.
New Pathway for COPD Biomarker Development
A study from Philip Morris International has highlighted multi-lipid profiling as a potential new pathway for COPD biomarker development.
Stiffening a Blow to Cancer Cells
Researchers develop a way to predict how a tumor tissue's physical properties affect its response to chemotherapy drugs.
Anti-Cancer Drug Uses Tumour mRNA to Identify Responders
Phase I study of novel anti-cancer drug uses tumour mRNA expression to identify patients who will respond to the drug.
New Strategy for Choosing Cancer Drugs
Device can predict tumor responses by measuring cell growth after drug exposure.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,100+ scientific videos